Comparative Performance of Different Nanostructured Electrochemical Sensors on Insulin Detection

New advancements in the management of type I diabetic patients (T1DM) call for a new generation of monitoring systems based upon an array of metabolic biosensors including sensors for insulin detection. Blood insulin values are always less than 270 pM; therefore, specifically designed insulin sensors have to provide a limit of detection in the range of few pico-molar units. At present, electrochemical sensors are one of the best options to provide low-cost technologies for diabetes mellitus monitoring and treatment. Moreover, modern nanotechnology permits to improve further their performances by providing new materials, structured at the nanoscale (i.e., carbon nanotubes), which alter the original sensor properties when used for both in vivo and in vitro biosensing applications. A recent article in literature has proposed a solution based on electrochemical sensors that promise performances in line with above-mentioned insulin detection requirements. However, data presented in this paper show that such a promise is still overestimated, and an electrochemical sensor capable of insulin detection within the physiological range is still beyond the present state of the art even when adopting nanostructured working electrodes.

[1]  Fausto Lucarelli,et al.  Evaluating the Clinical Accuracy of GlucoMen®Day: A Novel Microdialysis-Based Continuous Glucose Monitor , 2010, Journal of diabetes science and technology.

[2]  Giovanni De Micheli,et al.  Multi-panel drugs detection in human serum for personalized therapy. , 2011, Biosensors & bioelectronics.

[3]  Ray H. Baughman,et al.  Direct electron transfer of glucose oxidase on carbon nanotubes , 2002 .

[4]  Sandro Carrara,et al.  Direct electron transfer between cytochrome P450scc and gold nanoparticles on screen-printed rhodium-graphite electrodes. , 2005, Biosensors & bioelectronics.

[5]  Giovanni De Micheli,et al.  Electrochemical Detection of Anti-Breast-Cancer Agents in Human Serum by Cytochrome P450-Coated Carbon Nanotubes , 2012, Sensors.

[6]  Joseph Wang,et al.  A Decade with Bismuth‐Based Electrodes in Electroanalysis , 2010 .

[7]  G. Tucker,et al.  The Effect of Metformin on Glycaemic Control, Intermediary Metabolism and Blood Pressure in Non‐insulin‐dependent Diabetes Mellitus , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[8]  Giovanni De Micheli,et al.  Sensitivity enhancement by carbon nanotubes: Applications to stem cell cultures monitoring , 2009, 2009 Ph.D. Research in Microelectronics and Electronics.

[9]  Sandro Carrara,et al.  Bio/CMOS Interfaces and Co-Design , 2012 .

[10]  B. Ahrén,et al.  Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice. , 2010, European journal of pharmacology.

[11]  V. Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[12]  Sandro Carrara,et al.  Semiconductor nanoparticles for quantum devices , 1998 .

[13]  A. Salimi,et al.  Electrooxidation of insulin at silicon carbide nanoparticles modified glassy carbon electrode , 2009 .